Mosanna Therapeutics (Series A)

Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
June 10, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$80,000,000
Company Info
Company Description
Mosanna Therapeutics is a biotech company rethinking treatment of obstructive sleep apnea (OSA) by developing an easy-to-use nighttime nasal spray that helps restore the body's natural airway control.
Market
Obstructive Sleep Apnea Treatment
Location
Redwood City, California, USA
Coinvestors
Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Broadview Ventures, Norwest, Forty51 Ventures, Supermoon Capital, High-Tech Grunderfonds (HTGF)
Links
Back to Home Back to Biotechnology Deals View Funding Announcement